Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental ...

The FDA has introduced a new fast-track review system for three psychedelic drug programs targeting PTSD and depression, potentially cutting approval review times to one or two months once ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29 ...

The FDA has launched a fast-track program for psychedelic therapies following President Trump’s executive order to accelerate treatments for serious mental illnesses. The initiative offers priority ...